2,3-substituted 5,6-diaryl-pyrazine derivatives as CB1 modulators

Details for Australian Patent Application No. 2004247614 (hide)

Owner AstraZeneca AB

Inventors Wilstermann, Michael; Cheng, Leifeng

Agent Davies Collison Cave

Pub. Number AU-B-2004247614

PCT Pub. Number WO2004/111039

Priority 0314261.9 19.06.03 GB

Filing date 16 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 28 February 2008

International Classifications

C07D 209/54 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 241/24 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/111039 Priority application(s): WO2004/111039

28 February 2008 Application Accepted

  Published as AU-B-2004247614

26 June 2008 Standard Patent Sealed

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247615-2-substituted 5,6-diaryl-pyrazine derivatives as CB1 modulators

2004247612-Processes for preparing (2S)-3-(4-{2-(amino)-2-oxoethoxy}phen yl)-2-ethoxypropanoic acid derivatives